18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer

doi:10.3748/wjg.v17.i2.231

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4633)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

379

HTML

3884

Figures (1-1)

186

Tables (1-3)

184

Sum=4633

Jan 14, 2011 (publication date) through Sep 18, 2024

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 14, 2011; 17(2): 231-235
Published online Jan 14, 2011. doi: 10.3748/wjg.v17.i2.231

Table 2 Correlations between tumor size and sensitivity of positron emission tomography, computed tomography, magnetic resonance imaging or tumor markers

TS (cm)	n	PET (%)	CT (%)	MRI (%)	CEA (%)	CA19-9 (%)
TS1 ( ≤ 2)	5	100^a	40	0	0	40
TS2 (> 2, ≤ 4)	15	93	93	89	20	73
TS3-4 (> 4)	11	100	100	100	73	91

TS: Tumor size; PET: Positron emission tomography; CT: Computed tomography; MRI: Magnetic resonance imaging; CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 19-9.

^aP = 0.002 vs MRI or CEA, P = 0.038 vs CT or CA19-9.

Citation: Okano K, Kakinoki K, Akamoto S, Hagiike M, Usuki H, Yamamoto Y, Nishiyama Y, Suzuki Y. ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer. World J Gastroenterol 2011; 17(2): 231-235
URL: https://www.wjgnet.com/1007-9327/full/v17/i2/231.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i2.231